Xuzhao Zhang
Xuzhao Zhang
Hangzhou, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma | Relapse Multiple Myeloma | Recruiting | Not applicable | 2026-01-22 | NCT07359014 |